A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer

BJU International

Volumn 101, Issue 11, 2008, Pages 1454-1460

  Hellwinkel, Olaf J C ^a   Rogmann, Jan Peer ^a   Asong, Legrehndem E ^a   Luebke, Andreas M ^a   Eichelberg, Christian ^a   Ahyai, Sascha ^a   Isbarn, Hendrik ^a   Graefen, Markus ^a   Huland, Hartwig ^a   Schlomm, Thorsten ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

FOXO; PI3 kinase; PKB AKT; Premalignant alterations; Prostate carcinoma; PTEN

Indexed keywords

INTEGRIN LINKED KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE P85 ALPHA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CELL METABOLISM; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVITY; GENE REPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; PRECANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 43049120043     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07540.x     Document Type: Article

References (34)

1. Brader S, Eccles SA. Phosphoinositide 3-kinase signalling pathways in tumour progression, invasion and angiogenesis. Tumori 2004 90 : 2 8
2. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002 296 : 1655 7
3. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002 14 : 381 95
4. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005 9 : 59 71
5. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000 346 : 561 76
6. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002 2 : 489 501
7. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 1998 18 : 1379 87
8. Kieffer N, Schmitz M, Plancon S et al. ILK as a potential marker gene to ascertain specific adenocarcinoma cell mRNA isolation from frozen prostate biopsy tissue sections. Int J Oncol 2005 26 : 1549 58
9. Kang S, Song J, Kang J et al. Suppression of the alpha-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death. Biochem Biophys Res Commun 2005 329 : 6 10
10. Dreher T, Zentgraf H, Abel U et al. Reduction of PTEN and p27kip1 expression correlates with tumour grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies. Virchows Arch 2004 444 : 509 17
11. Alessi DR, Andjelkovic M, Caudwell B et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996 15 : 6541 51
12. Liang K, Lu Y, Li X et al. Differential roles of phosphoinositide- dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to paclitaxel, doxorubicin, and gemcitabine. Mol Pharmacol 2006 70 : 1045 52
13. Nakatani K, Thompson DA, Barthel A et al. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 1999 274 : 21528 32
14. Knobbe CB, Reifenberger J, Blaschke B, Reifenberger G. Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas. J Natl Cancer Inst 2004 96 : 483 6
15. Gao T, Furnari F, Newton AC. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumour growth. Mol Cell 2005 18 : 13 24
16. Calin GA, di Iasio MG, Caprini E et al. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 2000 19 : 1191 5
17. Hu MC, Lee DF, Xia W et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004 117 : 225 37
18. Lynch RL, Konicek BW, McNulty AM et al. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation. Mol Cancer Res 2005 3 : 163 9
19. Dong XY, Chen C, Sun X et al. FOXO1A is a candidate for the 13q14 tumour suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res 2006 66 : 6998 7006
20. Modur V, Nagarajan R, Evers BM, Milbrandt J. FOXO proteins regulate tumour necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 2002 277 : 47928 37
21. Schlomm T, Luebke AM, Sultmann H et al. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis. Int J Oncol 2005 27 : 713 20
22. Schlomm T, Nakel E, Lubke A et al. Marked gene transcript level alterations occur early during radical prostatectomy. Eur Urol 2008 53 : 333 46
23. Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001 353 : 417 39
24. Bellacosa A, Kumar CC, Di Cristofano A, Testa JR. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 2005 94 : 29 86
25. Woscholski R, Dhand R, Fry MJ, Waterfield MD, Parker PJ. Biochemical characterization of the free catalytic p110 alpha and the complexed heterodimeric p110 alpha.p85 alpha forms of the mammalian phosphatidylinositol 3-kinase. J Biol Chem 1994 269 : 25067 72
26. Stokoe D. The phosphoinositide 3-kinase pathway and cancer. Expert Rev Mol Med 2005 7 : 1 22
27. Coffey JC, Wang JH, Smith MJ et al. Phosphoinositide 3-kinase accelerates postoperative tumour growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. Novel role for an old enemy. J Biol Chem 2005 280 : 20968 77
28. Graff JR, Deddens JA, Konicek BW et al. Integrin-linked kinase expression increases with prostate tumour grade. Clin Cancer Res 2001 7 : 1987 91
29. Sakai T, Li S, Docheva D et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 2003 17 : 926 40
30. Humphrey PA. Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol 2004 17 : 292 306
31. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995 274 : 626 31
32. Allsbrook WC Mangold KA, Johnson MH, Lane RB, Lane CG, Epstein JI. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist. Hum Pathol 2001 32 : 81 8
33. Oyama T, Allsbrook WC Kurokawa K et al. A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States. Arch Pathol Lab Med 2005 129 : 1004 10
34. True L, Coleman I, Hawley S et al. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci USA 2006 103 : 10991 6